deferasirox
- Product NDC
- 69238-1704
- 11-digit product format
- 692381704
- Labeler code
- 69238
- Product ID
- 69238-1704_30a9b4e3-6d26-43b3-87ba-855df34c9e8d
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- deferasirox
- Dosage form
- GRANULE
- Route
- ORAL
- Labeler
- Amneal Pharmaceuticals NY LLC
- Application
- ANDA214194
- Marketing category
- ANDA
- Marketing start
- 2021-02-09
- Marketing end
- 0000-00-00
- Substance
- DEFERASIROX
- Active strength
- 360 mg/1
- Pharmacologic classes
- Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Iron Chelating Activity [MoA], Iron Chelator [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 69238-1704 | DEFERASIROX GRANULE [AMNEAL PHARMACEUTICALS NY LLC] | 14 | Legacy NDC | 20231230_19f4b412-3d35-4e31-80b6-f13d26c300c5.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 69238-1704-1 | 69238170401 | 1 GRANULE in 1 PACKET (69238-1704-1) | 1 granule | 2021-02-09 | 0000-00-00 | No | No | Current |
| 69238-1704-3 | 69238170403 | 30 GRANULE in 1 CARTON (69238-1704-3) | 30 granule | 2021-02-09 | 0000-00-00 | No | No | Current |